This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK

CompletedOBSERVATIONAL
Enrollment

319

Participants

Timeline

Start Date

January 27, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Focal Onset SeizureEpilepsy
Trial Locations (23)

13005

Centre Hospitalier Universitaire (CHU) de Marseille - Hopital de la Timone, Marseille

13509

Neurologie - Stroke Unit - Zentrum für Epilepsie, Reinickendorf

16321

Epilepsieklinik Tabor, Bernau bei Berlin

22297

Evangelische Krankenhaus Alsterdorf, Hamburg

33617

Epilepsy Center Bethel hospital Mara, Bielefeld

35000

CHU Rennes - Pontchaillou Hospital, Rennes

35043

Epilepsiezentrum Hessen, Klinik für Neurologie, Philipps Universität Marburg - Standort Marburg, Marburg

53127

Klinik und Poliklinik für Epileptologie, Universitätsklinikum Bonn, Bonn

54000

CHRU de Nancy -Hopital Central, Service de Neurologie, Nancy

59037

CHRU de Lille - Hôpital Roger Salengro (LILLE), Lille

60528

Epilepsy Center Frankfurt Rhine-Main Neurocenter, Frankfurt am Main

67098

CHU de Strasbourg - Hôpital de Hautepierre, Strasbourg

69677

Hôpital Pierre Wertheimer - Hopsices Civils de Lyon, Bron

72016

Universitätsklinikum Tubingen, Tübingen

75013

Hôpital de la Pitié-Salpêtrière, Paris

76000

CHU de Rouen Hôpital Charles-NicolleService de Neurophysiologie, Rouen

77694

Diakonie Kork Epilepsiezentrum, Kehl

79106

Klinik für Neurochirurgie Uniklinik Freiburg -, Freiburg im Breisgau

91054

Neurologische Klinik, Erlangen

01454

Epilepsiezentrum Kleinwachau gGmbH, Radeberg

SE5 9RS

King's College Hospital NHS Foundation Trust, London

WC1N 3BG

UCLH NHS Trust Epilepsy Department, London

NE1 4LP

The Newcastle upon Tyne Hospitals, Newcastle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hippocrates Research

OTHER

lead

Aziende Chimiche Riunite Angelini Francesco S.p.A

INDUSTRY

NCT05747001 - This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK | Biotech Hunter | Biotech Hunter